[ Price : $8.95]
FDA warns South Koreas Huons Co. about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
A Skadden Insights post raises the concern of FDA-regulated companies caused by the significant leadership changes at the agency.[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially high-risk device issue involving introducer kits used w...[ Price : $8.95]
FDA warns Amazon it is marketing unapproved new drugs on its Web site.[ Price : $8.95]
Former FDA commissioner Scott Gottlieb supports the agency's newly announced initiative to accelerate early-stage clinical trials...[ Price : $8.95]
Regenxbio reaches an agreement with FDA on a path toward a potential accelerated approval of Navsunli (clemidsogene lanparvovec-sn...[ Price : $8.95]
A new journal article finds substantial differences in how major international regulators evaluate and approve oncology drugs that...[ Price : $8.95]
Former FDA commissioner Scott Gottlieb urges federal health officials to restore scientific leadership at the agency's medical pro...